Serveur d'exploration H2N2 - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Larisa Rudenko »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Larisa Gubareva < Larisa Rudenko < Larisa V. Gubareva  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
000109 (2004) Thomas Palker [États-Unis] ; Irina Kiseleva ; Kimberly Johnston ; Qin Su ; Timothy Toner ; Christopher Szymkowiak ; Wan-Sang Kwan ; Boris Rubin ; Luba Petrukhin ; Joan Wlochowski ; Juanita Monteiro ; Nikolai Kraiouchkine ; Daniel Distefano ; Larisa Rudenko ; Alan Shaw ; Rima YouilProtective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
000367 (2008) Larisa Rudenko [Russie] ; Julia Desheva ; Sergey Korovkin ; Alexander Mironov ; Andrey Rekstin ; Elena Grigorieva ; Svetlana Donina ; Alexandra Gambaryan ; Anton KatlinskySafety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I-II clinical trials).
000615 (2011) Irina Isakova-Sivak [États-Unis] ; Li-Mei Chen ; Yumiko Matsuoka ; J Theo M. Voeten ; Irina Kiseleva ; Jacco G M. Heldens ; Han Van Den Bosch ; Alexander Klimov ; Larisa Rudenko ; Nancy J. Cox ; Ruben O. DonisGenetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2).
000655 (2011) Larisa Rudenko [Russie] ; Han Van Den Bosch ; Irina Kiseleva ; Alexander Mironov ; Anatoly Naikhin ; Natalie Larionova ; Dimitry BushmenkovLive attenuated pandemic influenza vaccine: clinical studies on A/17/California/2009/38 (H1N1) and licensing of the Russian-developed technology to WHO for pandemic influenza preparedness in developing countries.
000693 (2011) Kortney M. Gustin [États-Unis] ; Taronna R. Maines ; Jessica A. Belser ; Neal Van Hoeven ; Xuihua Lu ; Libo Dong ; Irina Isakova-Sivak ; Li-Mei Chen ; J Theo M. Voeten ; Jacco G M. Heldens ; Han Van Den Bosch ; Nancy J. Cox ; Terrence M. Tumpey ; Alexander I. Klimov ; Larisa Rudenko ; Ruben O. Donis ; Jacqueline M. KatzComparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets.
000A21 (2014) Irina Isakova-Sivak [États-Unis, Russie] ; Li-Mei Chen [États-Unis] ; Melissa Bourgeois [États-Unis] ; Yumiko Matsuoka [États-Unis] ; J. Theo M. Voeten [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] ; Han Van Den Bosch [Pays-Bas] ; Alexander Klimov [États-Unis] ; Larisa Rudenko [Russie] ; Nancy J. Cox [États-Unis] ; Ruben O. Donis [États-Unis]Characterization of Reverse Genetics-Derived Cold-Adapted Master Donor Virus A/Leningrad/134/17/57 (H2N2) and Reassortants with H5N1 Surface Genes in a Mouse Model
000A64 (2014) Irina Isakova-Sivak [Russie] ; J Rgen De Jonge [Pays-Bas] ; Tatiana Smolonogina [Russie] ; Andrey Rekstin [Russie] ; Geert Van Amerongen [Pays-Bas] ; Harry Van Dijken [Pays-Bas] ; Justin Mouthaan [Pays-Bas] ; Paul Roholl [Pays-Bas] ; Victoria Kuznetsova [Russie] ; Elena Doroshenko [Russie] ; Vadim Tsvetnitsky [États-Unis] ; Larisa Rudenko [Russie]Development and Pre-Clinical Evaluation of Two LAIV Strains against Potentially Pandemic H2N2 Influenza Virus
000B24 (2015) Larisa Rudenko [Russie] ; Irina Isakova-SivakPandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus.
000B38 (2014) Andrey Rekstin [Russie] ; Yulia Desheva [Russie] ; Irina Kiseleva [Russie] ; Ted Ross [États-Unis] ; David Swayne [États-Unis] ; Larisa Rudenko [Russie]Live Attenuated Influenza H7N3 Vaccine is Safe, Immunogenic and Confers Protection in Animal Models.
000B54 (2015) Irina Isakova-Sivak [Russie] ; Marina Stukova [Russie] ; Mariana Erofeeva [Russie] ; Anatoly Naykhin [Russie] ; Svetlana Donina [Russie] ; Galina Petukhova [Russie] ; Victoria Kuznetsova [Russie] ; Irina Kiseleva [Russie] ; Tatiana Smolonogina [Russie] ; Irina Dubrovina [Russie] ; Maria Pisareva [Russie] ; Alexandra Nikiforova [Russie] ; Maureen Power [États-Unis] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie]H2N2 live attenuated influenza vaccine is safe and immunogenic for healthy adult volunteers
000C29 (2015) Irina Kiseleva [Russie] ; Irina Dubrovina [Russie] ; Ekaterina Fedorova [Russie] ; Natalie Larionova [Russie] ; Irina Isakova-Sivak [Russie] ; Ekaterina Bazhenova [Russie] ; Maria Pisareva [Russie] ; Victoria Kuznetsova [Russie] ; Jorge Flores [États-Unis] ; Larisa Rudenko [Russie]Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses.
000C37 (2016) Svetlana Shcherbik [États-Unis] ; Nicholas Pearce [États-Unis] ; Irina Kiseleva [Russie] ; Natalie Larionova [Russie] ; Larisa Rudenko [Russie] ; Xiyan Xu [États-Unis] ; David E. Wentworth [États-Unis] ; Tatiana Bousse [États-Unis]Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses.
000C56 (2016) J Rgen De Jonge [Pays-Bas] ; Irina Isakova-Sivak [Russie] ; Harry Van Dijken [Pays-Bas] ; Sanne Spijkers [Pays-Bas] ; Justin Mouthaan [Pays-Bas] ; Rineke De Jong [Pays-Bas] ; Tatiana Smolonogina [Russie] ; Paul Roholl [Pays-Bas] ; Larisa Rudenko [Russie]H7N9 Live Attenuated Influenza Vaccine Is Highly Immunogenic, Prevents Virus Replication, and Protects Against Severe Bronchopneumonia in Ferrets.
000D18 (2016) Irina Isakova-Sivak [Russie] ; Daniil Korenkov [Russie] ; Tatiana Smolonogina [Russie] ; Tatiana Tretiak [Russie] ; Svetlana Donina [Russie] ; Andrey Rekstin [Russie] ; Anatoly Naykhin [Russie] ; Svetlana Shcherbik [États-Unis] ; Nicholas Pearce [États-Unis] ; Li-Mei Chen [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa Rudenko [Russie]Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model
000D50 (2017) Andrey Rekstin [Russie] ; Irina Isakova-Sivak [Russie] ; Galina Petukhova [Russie] ; Daniil Korenkov [Russie] ; Igor Losev [Russie] ; Tatiana Smolonogina [Russie] ; Tatiana Tretiak [Russie] ; Svetlana Donina [Russie] ; Svetlana Shcherbik [États-Unis] ; Tatiana Bousse [États-Unis] ; Larisa Rudenko [Russie]Immunogenicity and Cross Protection in Mice Afforded by Pandemic H1N1 Live Attenuated Influenza Vaccine Containing Wild-Type Nucleoprotein
000E41 (2017) Irina Kiseleva [Russie] ; Natalie Larionova [Russie] ; Larisa Rudenko [Russie]Live Attenuated Reassortant Vaccines Based on A/Leningrad/134/17/57 Master Donor Virus Against H5 Avian Influenza.
000F30 (2018) Larisa Rudenko ; Irina Kiseleva ; Elena Krutikova ; Ekaterina Stepanova ; Irina Isakova-Sivak ; Svetlana Donina ; Andrey Rekstin ; Maria Pisareva ; Ekaterina Bazhenova ; Tatiana Kotomina ; Anastasia Katelnikova ; Arman Muzhikyan ; Valery Makarov ; Erin Grace Sparrow ; Guido TorelliTwo Live Attenuated Vaccines against Recent Low–and Highly Pathogenic H7N9 Influenza Viruses Are Safe and Immunogenic in Ferrets
000F96 (2019) Irina Isakova-Sivak [Russie] ; Victoria Matyushenko [Russie] ; Tatiana Kotomina [Russie] ; Irina Kiseleva [Russie] ; Elena Krutikova [Russie] ; Svetlana Donina [Russie] ; Andrey Rekstin [Russie] ; Natalia Larionova [Russie] ; Daria Mezhenskaya [Russie] ; Konstantin Sivak [Russie] ; Arman Muzhikyan [Russie] ; Anastasia Katelnikova [Russie] ; Larisa Rudenko [Russie]Sequential Immunization with Universal Live Attenuated Influenza Vaccine Candidates Protects Ferrets against a High-Dose Heterologous Virus Challenge
001001 (2019) Svetlana Shcherbik [États-Unis] ; Nicholas Pearce [États-Unis] ; Paul Carney [États-Unis] ; Ekaterina Bazhenova [Russie] ; Natalie Larionova [Russie] ; Irina Kiseleva [Russie] ; Larisa Rudenko [Russie] ; Amrita Kumar [États-Unis] ; Cynthia S. Goldsmith [États-Unis] ; Vivien Dugan [États-Unis] ; James Stevens [États-Unis] ; David E. Wentworth [États-Unis] ; Tatiana Bousse [États-Unis]Evaluation of A(H1N1)pdm09 LAIV vaccine candidates stability and replication efficiency in primary human nasal epithelial cells

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Larisa Rudenko" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Larisa Rudenko" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Larisa Rudenko
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021